Recently, it has been suggested that leiomyomas with bizarre nuclei can be divided into two subtypes based primarily on nuclear features; some tumors show significantly higher rates of HMGA2 immunoreactivity and frequent MED12 mutations and the others may occasionally be related to FH mutations [51]. This evidence concerns the gene FH and leiomyoma.